We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£425.00
It has never been this cheap. We have no record of a lower price.
£425 today · cheaper than every other day in the last 3 months
Anti-Migraine Drug Outlook North America & Caribbean Study
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 87 days · 87 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 87 days • 1 price levels
Price Analysis
Most common price: £425 (87 days, 100.0%)
Price range: £425 - £425
Price levels: 1 different prices over 87 days
Description
Key Features
Covers the economic outlook for anti-migraine drugs in North America and the Caribbean from 2016 to 2021.
Provides latent demand estimates, or potential industry earnings (P.I.E.), in millions of U.S. dollars for each year.
Includes regional and global market share percentages to help compare individual countries against the broader market.
Uses econometric models to project fundamental economic dynamics across various countries in the study area.
Offers comparative benchmarks that allow for quick assessment of a country's market standing versus its neighbors.
Product Specifications
- Format
- paperback
- ASIN
- B0161TEZP4
- Domain
- Amazon UK
- Release Date
- 21 May 2015
- Listed Since
- 01 October 2015
Similar Products You Might Like
Anti-Migraine Drug Outlook Latin America 2016-2021 Study
Anti-Migraine Drugs in Europe Outlook 2016-2021 Report
Anti-Migraine Drug Outlook in Asia 2016-2021 Study
Anti-Migraine Drug Outlook: Africa & Middle East Study
Anti-Migraine Drug Outlook in Oceana 2016-2021 Study
The 2023-2028 Outlook for Anti-Migraine Drugs in China
The 2023-2028 Outlook for Anti-Migraine Drugs in Japan
The 2013-2018 Outlook for Anti-Migraine Drugs in Europe & the Middle East
Anti-Migraine Drug Outlook in Middle East (2011-2016)
The 2013-2018 Outlook for Anti-Migraine Drugs in Africa
The 2021-2026 World Outlook for Anti-Migraine Drugs
US Anti-Migraine Drug Market Outlook 2016-2021 Study
US Anti-Migraine Drug Market Outlook 2023-2028 Study
Anti-Migraine Drug Outlook in Greater China 2016-2021
The 2016-2021 Outlook for Anti-Migraine Drugs in India
Anti-Migraine Drugs in India Outlook 2023-2028 Study
2025-2030 World Outlook for Anti-Migraine Drugs Study
Price unavailable
The 2023-2028 World Outlook for Acute-Treatment Migraine Drugs
US Anti-Migraine Drug Outlook 2023-2028 - Zip Code Study
The 2016 Report on Anti-Migraine Drugs: World Market Segmentation by City
Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)
OmniScriptum
Management of Migraine Pain: Emerging Opportunities and Challenges
Springer
Migraine and Headache Disorders: Global Perspective - SDG3
Springer
Interventional Management of Migraines and Headache Disorders Book
Elsevier